Abstract CT510: A phase I clinical trial of 3D-pluripotent stem cell biologics in heavily treated advanced NSCLC patients

Authors: Meijuan Huang, Xiancheng Chen, Yi Qin, Yaling Long, Qian Li, Yanna Zhang, Min Yu, Panyan Hou, Nanxi Liu, Yanying Li, Yang Yu, Xiaojuan Zhou, Youling Gong, Ke Wang, Jiang Zhu, Feng Peng, Yongsheng Wang, You Lu, Yuquan Wei

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-ct510

Source: Full article